These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35755945)
1. Structural basis for the neurotropic AAV9 and the engineered AAVPHP.eB recognition with cellular receptors. Xu G; Zhang R; Li H; Yin K; Ma X; Lou Z Mol Ther Methods Clin Dev; 2022 Sep; 26():52-60. PubMed ID: 35755945 [TBL] [Abstract][Full Text] [Related]
2. Structural basis of receptor usage by the engineered capsid AAV-PHP.eB. Jang S; Shen HK; Ding X; Miles TF; Gradinaru V Mol Ther Methods Clin Dev; 2022 Sep; 26():343-354. PubMed ID: 36034770 [TBL] [Abstract][Full Text] [Related]
3. Context-Specific Function of the Engineered Peptide Domain of PHP.B. Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767 [TBL] [Abstract][Full Text] [Related]
4. Cryo-EM structure of adeno-associated virus 4 at 2.2 Å resolution. Zane G; Silveria M; Meyer N; White T; Duan R; Zou X; Chapman M Acta Crystallogr D Struct Biol; 2023 Feb; 79(Pt 2):140-153. PubMed ID: 36762860 [TBL] [Abstract][Full Text] [Related]
5. Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor. Pillay S; Zou W; Cheng F; Puschnik AS; Meyer NL; Ganaie SS; Deng X; Wosen JE; Davulcu O; Yan Z; Engelhardt JF; Brown KE; Chapman MS; Qiu J; Carette JE J Virol; 2017 Sep; 91(18):. PubMed ID: 28679762 [TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus 2 bound to its cellular receptor AAVR. Zhang R; Cao L; Cui M; Sun Z; Hu M; Zhang R; Stuart W; Zhao X; Yang Z; Li X; Sun Y; Li S; Ding W; Lou Z; Rao Z Nat Microbiol; 2019 Apr; 4(4):675-682. PubMed ID: 30742069 [TBL] [Abstract][Full Text] [Related]
7. Structural insight into the unique properties of adeno-associated virus serotype 9. DiMattia MA; Nam HJ; Van Vliet K; Mitchell M; Bennett A; Gurda BL; McKenna R; Olson NH; Sinkovits RS; Potter M; Byrne BJ; Aslanidi G; Zolotukhin S; Muzyczka N; Baker TS; Agbandje-McKenna M J Virol; 2012 Jun; 86(12):6947-58. PubMed ID: 22496238 [TBL] [Abstract][Full Text] [Related]
8. Adeno-Associated Virus Receptor-Binding: Flexible Domains and Alternative Conformations through Cryo-Electron Tomography of Adeno-Associated Virus 2 (AAV2) and AAV5 Complexes. Hu G; Silveria MA; Zane GM; Chapman MS; Stagg SM J Virol; 2022 Jul; 96(13):e0010622. PubMed ID: 35674430 [TBL] [Abstract][Full Text] [Related]
9. Cross-Species Permissivity: Structure of a Goat Adeno-Associated Virus and Its Complex with the Human Receptor AAVR. Large EE; Silveria MA; Weerakoon O; White TA; Chapman MS J Virol; 2022 Dec; 96(24):e0148422. PubMed ID: 36453885 [TBL] [Abstract][Full Text] [Related]
10. CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain. Mathiesen SN; Lock JL; Schoderboeck L; Abraham WC; Hughes SM Mol Ther Methods Clin Dev; 2020 Dec; 19():447-458. PubMed ID: 33294493 [TBL] [Abstract][Full Text] [Related]
11. Comparative Analysis of the Capsid Structures of AAVrh.10, AAVrh.39, and AAV8. Mietzsch M; Barnes C; Hull JA; Chipman P; Xie J; Bhattacharya N; Sousa D; McKenna R; Gao G; Agbandje-McKenna M J Virol; 2020 Feb; 94(6):. PubMed ID: 31826994 [TBL] [Abstract][Full Text] [Related]
14. Engineering a highly durable adeno-associated virus receptor for analytical applications. Yoshida K; Tsunekawa Y; Kurihara K; Watanabe K; Makino-Manabe Y; Wada M; Tanaka T; Ide T; Okada T Mol Ther Methods Clin Dev; 2023 Dec; 31():101157. PubMed ID: 38152699 [TBL] [Abstract][Full Text] [Related]
15. Divergent engagements between adeno-associated viruses with their cellular receptor AAVR. Zhang R; Xu G; Cao L; Sun Z; He Y; Cui M; Sun Y; Li S; Li H; Qin L; Hu M; Yuan Z; Rao Z; Ding W; Rao Z; Lou Z Nat Commun; 2019 Aug; 10(1):3760. PubMed ID: 31434885 [TBL] [Abstract][Full Text] [Related]
16. The Structure of an AAV5-AAVR Complex at 2.5 Å Resolution: Implications for Cellular Entry and Immune Neutralization of AAV Gene Therapy Vectors. Silveria MA; Large EE; Zane GM; White TA; Chapman MS Viruses; 2020 Nov; 12(11):. PubMed ID: 33218165 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site. Huang LY; Patel A; Ng R; Miller EB; Halder S; McKenna R; Asokan A; Agbandje-McKenna M J Virol; 2016 Jun; 90(11):5219-5230. PubMed ID: 26962225 [TBL] [Abstract][Full Text] [Related]
20. Enhanced sensitivity of neutralizing antibody detection for different AAV serotypes using HeLa cells with overexpressed AAVR. Zheng Z; Ye J; Leng M; Gan C; Tang N; Li W; Valencia CA; Dong B; Chow HY Front Pharmacol; 2023; 14():1188290. PubMed ID: 37188274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]